Clinical Trials
4 trialsNCT00238355 2025-04-27
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
OHSU Knight Cancer Institute
Phase 2 Terminated
NCT01501708 2016-05-10
Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection
Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT00418951 2012-08-07
Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01207128 2012-04-20
Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis
University of Arkansas
Phase 2 Withdrawn